Different from ICG-001, IWR-1-endo inhibits the Wnt/β-catenin pathway by stabilizing the Axin-scaffolded destruction complex [24], and it has been used to treat gliomas in vivo [25]. This evidence concerns the gene AXIN1 and central nervous system cancer.